Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > CADL Candel Therapeutics > Detailed Quotes

CADL Candel Therapeutics

3.200
+0.030+0.95%
Close 09/29 16:00 ET
High
3.290
Open
3.019
Turnover
10.82K
Low
3.019
Pre Close
3.170
Volume
3.45K
Market Cap
92.45M
P/E(TTM)
Loss
52wk High
11.980
Shares
28.89M
P/E(Static)
Loss
52wk Low
2.805
Float Cap
40.68M
Bid/Ask %
-100.00%
Historical High
14.780
Shs Float
12.71M
Volume Ratio
0.20
Historical Low
2.805
Dividend TTM
--
Div Yield TTM
--
P/B
1.54
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.03%
Amplitude
8.54%
Avg Price
3.134
Lot Size
1
Float Cap
40.68M
Bid/Ask %
-100.00%
Historical High
14.780
Shs Float
12.71M
Volume Ratio
0.20
Historical Low
2.805
Dividend TTM
--
P/B
1.54
Dividend LFY
--
Turnover Ratio
0.03%
Amplitude
8.54%
Avg Price
3.134
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Candel Therapeutics, Inc. operates as a biopharmaceutical company that develops and commercializes cancer immunotherapy drugs. It offers aglatimagene besadenovec (CAN-2409), a replication-deficient adenovirus that delivers within infected cancer cells the herpes simplex virus thymidine kinase (HSV-tk) gene. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.
CEO: Dr. Paul Peter Tak, M.D.,PhD
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...